Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANTA-P: LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery
NCT07168421Phase 4Recruiting
- Sponsor
- Insel Gruppe
- Start
- Apr 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of landiolol in Myocardial injury (2 arms), sponsored by Insel Gruppe. Primary endpoint: Time perioperative heart rate in target range. Started Apr 2026; status: recruiting.
02
Drugs
landiolol
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT07168421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07168421.